Loading organizations...
Cell-based regenerative therapies for spine-related degenerative diseases.
DiscGenics has raised $64.0M across 2 funding rounds.
DiscGenics has raised $64.0M in total across 2 funding rounds.
DiscGenics has raised $64.0M in total across 2 funding rounds.
DiscGenics's investors include Colin Lee Novick, CareNet of Japan, Eagle Fund SP1, Medical Incubator Japan, Mitsubishi UFJ Capital.
DiscGenics has raised $64.0M across 2 funding rounds. Most recently, it raised $50.0M Series C in August 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 27, 2020 | $50.0M Series C | Colin Lee Novick | CareNet of Japan, Eagle Fund SP1, Medical Incubator Japan, Mitsubishi UFJ Capital |
| Sep 26, 2017 | $14.0M Series B | Mitsubishi UFJ Capital |